Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Nov
5
2019
Evidence of Copying Must Be Considered In Obviousness Analysis Foley & Lardner LLP
Jun
1
2016
Two Recent Decisions Put Alice "Step One" on Center Stage at The Federal Circuit Foley & Lardner LLP
Jul
7
2016
Federal Circuit Finds Cryopreservation Method Patent Eligible Foley & Lardner LLP
Aug
1
2016
You Cannot Create A Restrictive Covenant Out of Thin Air Foley & Lardner LLP
Nov
21
2016
Federal Attack on Non-Competes Likely Another Casualty of Election Foley & Lardner LLP
Nov
18
2020
What Arthrex Could Mean for the PTAB Going Forward Foley & Lardner LLP
Jan
22
2021
Setting the Stage: Court Sets Oral Argument in Arthrex Cases Foley & Lardner LLP
Feb
2
2021
USPTO Changes Small Entity Rules To Promote CRADAs Foley & Lardner LLP
Jun
26
2017
USPTO Extends Cancer Immunotherapy Pilot Program Foley & Lardner LLP
Aug
8
2017
A Look At The USPTO Patent Eligible Subject Matter Report Foley & Lardner LLP
Mar
5
2015
STRONG Patents Act Would Fix Micro Entity Gap Foley & Lardner LLP
Mar
15
2022
Understanding the Metaverse Foley & Lardner LLP
Jun
27
2022
Looking Below the Surface for Claim Construction Foley & Lardner LLP
Dec
20
2017
Expanded PTAB Panel Finds Sovereign Immunity Waived By Patent Enforcement Foley & Lardner LLP
Jan
2
2018
New Year's Resolutions For The U.S. Patent System Foley & Lardner LLP
Jul
22
2015
Federal Circuit Finds Biosimilar Patent Dispute Resolution Procedures Optional Foley & Lardner LLP
Jul
28
2015
America Invents Act: Can You File An RCE In That U.S. National Stage Application? Foley & Lardner LLP
Jul
30
2015
Sanofi Seeks Inter Partes Review Of Cabilly Patent Foley & Lardner LLP
Nov
8
2022
How Intellectual Property Fits in Cloud Computing and SaaS Business Models Foley & Lardner LLP
Aug
21
2015
Will New PTAB Rules Impact IPRs Filed By Kyle Bass Hedge Fund? Foley & Lardner LLP
Aug
25
2015
PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge Foley & Lardner LLP
Mar
27
2018
Case to Watch: Goldman v. Breitbart, involving embedded Tweets of Tom Brady recruiting Kevin Durant in the Hamptons Foley & Lardner LLP
Apr
4
2018
Second Circuit Suggests that the Value of an Accused Secondary Use Dictates What Constitutes Fair Use Foley & Lardner LLP
Dec
19
2022
Why Venture Capital Investors Are Betting on Generative AI Foley & Lardner LLP
Sep
2
2015
PTAB Requests Additional Briefing On Hedge Fund IPR Questions: A Decision May Be Near Foley & Lardner LLP
Jan
4
2023
Unleashing American Innovators Act Slashes USPTO Small Entity Fees Foley & Lardner LLP
Feb
13
2023
Senate Judiciary Committee Pushes Pharma Patents and Pricing Bills Forward Foley & Lardner LLP
Jun
5
2018
Federal Circuit Finds Incorporation By Reference Inadequate For Priority Claim Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins